Quanterix Corp (QTRX) stock
Close on Nov 13, 2026Market cap $138.57MP/E –Yield –
Quanterix Corp grew revenue 13.8% to $148.15M over the twelve months to Sep 30, 2026. Free cash flow was -$56.03M. At the latest close the market valued the company at $138.57M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $138.57M
- P/E ratio
- –
- Price to sales
- 0.94
- Price to book
- 0.63
- Dividend yield
- –
- Free cash flow yield
- -40.44%
Fundamentals
- Revenue
- $148.15M
- Net income
- -$111.18M
- EPS, diluted
- -$2.36
- Free cash flow
- -$56.03M
- Book value per share
- $4.63
- Diluted shares
- 47M
Trading
- Next earnings
- Mar 1, 2027 (estimated, after the close)
- Previous close
- $2.86
- Open
- $2.90
- Day's range
- $2.78 – $3.04
- Volume
- 394,293
- Average volume (20 days)
- 493,586
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 1.33
- 52-week range
- $2.15 – $8.77
- RSI (14 days)
- 47.8
- Volatility (1 year)
- 94.4%
- Relative volume
- 0.58×
- WACC
- 11.7%
On 1 of our idea list: More cash than they're worth
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | QTRX | S&P 500 | Difference | QTRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -7.0% | -3.0% | −3.9 pts | ||
| 3 months | +2.4% | -2.8% | +5.2 pts | ||
| Year to date | -53.9% | +11.5% | −65.4 pts | ||
| 1 year | -44.9% | +13.5% | −58.4 pts | ||
| 3 years | -85.8% | +77.7% | −163.5 pts | -47.9% | +21.1% |
| 5 years | -94.8% | +72.6% | −167.4 pts | -44.7% | +11.5% |
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Quanterix filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Update
About Quanterix
Laboratory Analytical Instruments
Quanterix Corporation is a life sciences company that provides ultra-sensitive translational research and spatial biology instruments, consumables, and laboratory services. Its proprietary Simoa platforms enable detection of protein biomarkers at concentrations down to the femtomolar range, while its spatial biology platforms allow multi-plexed cellular-level biomarker analysis in intact tissue. In addition to instruments such as the HD-X, SR-X, SP-X, PhenoCycler, and PhenoImager, the company sells consumable assay kits, reagents, and extended service contracts. It also delivers contract research services and clinical diagnostic testing, including laboratory developed tests, through its Accelerator Laboratory. Customers include research laboratories, contract research organizations, academic institutions, and bio-pharmaceutical companies.
Company profile, executives and historyQuanterix stock: common questions
What is Quanterix's stock price?
QTRX closed at $2.93 on Nov 13, 2026, up 2.45% on the day. Over the past 52 weeks it traded between $2.15 and $8.77.
What is Quanterix's market cap?
Quanterix was worth $138.57M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is QTRX's P/E ratio?
Quanterix lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.36), so it has no meaningful P/E ratio.
How much revenue does Quanterix make?
Quanterix reported revenue of $148.15M for the twelve months to Sep 30, 2026, up 13.8% from a year earlier.
Does Quanterix pay a dividend?
No. Quanterix has not paid a cash dividend over the last twelve months.
When does Quanterix report earnings next?
Quanterix is expected to report Q4 FY2026 results on Mar 1, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has QTRX stock performed over the past year?
Including dividends, QTRX returned -44.9% over the past year, against +13.5% for the S&P 500.
How many QTRX shares are sold short?
5M shares were sold short at the latest FINRA report, 10.98% of the float, or 10.7 days of average trading volume.
Who are Quanterix's competitors?
Companies most similar to Quanterix by business, industry and size include CTKB, PACB, HBIO, TXG, MASS.
See a number that looks wrong?